Welcome to the official website of Sichuan Purity Pharmaceutical Co., LTD.

About

Our History

Your location:Home>About>Our History

  • In 2025

    Deloitte China's Top 50 High Tech High Growth Companies in 2024.
    Top 100 New Economy Enterprises in Sichuan Province in 2024.
    Salmeterol and fluticasone dry powder inhalation approved.

  • In 2024

    2023 Deloitte China Rising Star.
    Dexmedetomidine Hydrochloride Nasal Spray approved.
    2024 Golden Panda Future Star.
    2023 Sichuan Science and Technology Awards‌‌.
    Formoterol Fumarate inhalation solution approved.

  • In 2023

    Levalbuterol Hydrochloride Inhalation Solution won the bid for the ninth batch of national centralized procurement.
    Budesonide Nasal Spray approved.
    2023 Deloitte Chengdu Rising Star.
    Sichuan Province's specialized, refined, unique, and innovative small and medium-sized enterprises.
    Innovation and Entrepreneurship Team of Tianfu Emei Plan.

  • In 2022

    Terbutaline Sulfate inhalation solution approved.
    Levalbuterol Hydrochloride Inhalation Solution approved.
    Terbutaline Sulfate Inhalation Solution won the bid for the seventh batch of national centralized procurement.

  • In 2021

    Budesonide Inhalation Suspension approved.
    Albuterol Sulfate and Ipratropium Bromide Inhalation Solution approved.
    Albuterol Sulfate Inhalation Solution won the bid for the fourth batch of national centralized procurement.
    Ipratropium Bromide Inhalation Solution,Albuterol Sulfate and Ipratropium Bromide Inhalation Solution,Budesonide Inhalation Suspension won the bid for the fifth batch of national centralized procurement.
    National high-tech enterprise.

  • In 2020

    Albuterol Sulfate Inhalation Solution approved.
    Ipratropium Bromide Inhalation Solution approved.
    Realize commercial production.

  • In 2019

    The production base was construced.

  • In 2018

    The first domestic new type of HFA-134a inhalation aerosol has passed the PK-BE test.

  • In 2017

    The construction of the production base has been initiated.

  • In 2016

    It obtained the clinical approval of the first inhalation aerosol.

  • In 2014

    The GMP pilot workshop was constructed.

  • In 2013

    The research and development center was constructed.

  • In 2012

    The company was established.